PFE · Pfizer Inc.

S&P 500 #88 · NYSE

Risiko 6/10 · Pharma Turnaround Play · $25.25 ▲ 2.35%

Kennzahlen

• Price $25.25
• Market cap $143.9B
• P/E (ttm) 19.27
• Div yield 6.97%
• 52-wk range $23.11 – $28.75
• Index rank #88 / —

Wichtigste Risiken

• COVID franchise revenue cliff (Revenue line) — HIGH
• Pipeline productivity uncertainty post-Seagen integration (Long-term holders) — HIGH
• Drug-pricing regulation (IRA Medicare negotiation) (Margins) — MED
• Dividend sustainability given cash flow pressure (Income investors) — MED

Fazit

Global pharma giant navigating a post-COVID revenue reset; elevated 7% yield signals market skepticism but deep pipeline and Seagen oncology assets offer upside optionality.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.